We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Flow chart of 3D and thermal imaging workflow and results.
Product News

TransCure bioServices Offers BioVolume 3D Imaging

The new service is a world first in 3D imaging, allowing the measurement and visualization of tumor growth in animal models across preclinical research, oncology and drug development.
Two hands holding jigsaw pieces representing a partnership.
Product News

Personalis and Moderna Sign New Agreement To Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials

The platform will be used to sequence genomic information from a patient’s tumor sample to identify the unique genetic mutations that are most likely to generate a tailored antitumor response.
Dr Alastair Smith, Chief Executive Officer of Avacta Group.
Product News

Avacta Announces Successful Completion of Fourth Dose Escalation in Phase 1 Clinical Study

Avacta Group plc announces that AVA6000 continues to show a very favorable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation phase 1 clinical trial.
The Mainz Biomed logo
Product News

Mainz Biomed Enrolls First Patient in eAArly DETECT Study Evaluating Integration of Novel mRNA Biomarkers Into ColoAlert

Mainz Biomed NV has announced the first patient has been enrolled in eAArly DETECT, Mainz’s U.S. extension of ColoFuture, its European feasibility study evaluating the integration of a portfolio of novel gene expression (mRNA) biomarkers into ColoAlert.
Small molecules
Product News

Cell-Permeable Small Molecules for Regenerative Medicine and Cancer Research

AMSBIO offers a wide range of small molecules to provide scientists with targeted tools to direct cell fates, making them crucial in areas including regenerative medicine and cancer research.
Red dots representing blood.
Product News

Mainz Biomed Announce IRB Approval and Initiation of US Pivotal FDA Clinical Study

Mainz Biomed has received approval from an independent Institutional Review Board for the protocol ReconAAsense, the Company’s US pivotal study to evaluate the clinical performance of its highly efficacious and easy-to-use detection test for colorectal cancer.
The QuantStudio Absolute Q dPCR System
Product News

New dPCR Liquid Biopsy Assays for QuantStudio Absolute Q dPCR System and Custom Design Tool Simplify Cancer Research

Thermo Fisher Scientific has introduced over 50 new Absolute Q Liquid Biopsy Assays to run on the Applied Biosystems QuantStudio Absolute Q dPCR System.
Rack of tubes containing blood in a laboratory.
Product News

Personalis and UCSF To Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer

Personalis has announced a collaboration with UC San Francisco that will deploy a personalized liquid biopsy-based research use only assay for a study of patients with colorectal cancer.
Backpacker standing at the top of a peak.
Product News

Nautilus Biotechnology Launches “First Access Challenge”

Open competition allows researchers to be among the first to access potentially groundbreaking proteomic data through the testing of twelve samples on Nautilus’ single-molecule protein analysis platform.
Schematic of human intestines.
Product News

Mainz Biomed Announces US Extension of ColoFuture Study To Evaluate Integration of Novel mRNA Biomarkers Into ColoAlert

Mainz Biomed has announced the initiation of eAArly DETECT, its US extension of ColoFuture, which is the Company’s European feasibility study evaluating the integration of a portfolio of novel gene expression (mRNA) biomarkers into ColoAlert.
Advertisement